06/05/2025
6:17 PM | Gad Thomas (Reporting)
Y-mAbs Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/28/2025
6:04 AM | Y-mAbs Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
05/14/2025
7:41 AM | Caligan Partners LP (Filed by)
Y-mAbs Therapeutics (Subject)
| Form SCHEDULE 13G | |
05/13/2025
6:26 AM | Y-mAbs Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
05/13/2025
6:33 AM | Y-mAbs Therapeutics (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
04/28/2025
7:14 PM | Y-mAbs Therapeutics (Filer)
| Form 10-K/A | |
03/11/2025
7:15 PM | Gad Thomas (Reporting)
Y-mAbs Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/11/2025
7:17 PM | Rossi Michael J (Reporting)
Y-mAbs Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/07/2025
3:32 PM | Gad Thomas (Reporting)
Y-mAbs Therapeutics (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
03/07/2025
3:36 PM | Smith Susan Laura (Reporting)
Y-mAbs Therapeutics (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
03/07/2025
3:40 PM | Rajah Vignesh (Reporting)
Y-mAbs Therapeutics (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
Get the Latest News and Ratings for YMAB and Related Stocks Enter your email address below to receive the latest news and analysts' ratings for Y-mAbs Therapeutics and its competitors with MarketBeat's FREE daily newsletter. |
03/07/2025
3:26 PM | Rossi Michael J (Reporting)
Y-mAbs Therapeutics (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
03/04/2025
6:48 AM | Y-mAbs Therapeutics (Filer)
| Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans | |
03/04/2025
6:15 AM | Y-mAbs Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
03/04/2025
6:24 AM | Y-mAbs Therapeutics (Filer)
| Form 10-K
Annual report pursuant to Section 13 or 15(d) | |
01/22/2025
5:57 PM | LaRocca John (Reporting)
Y-mAbs Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/22/2025
6:00 PM | Rossi Michael J (Reporting)
Y-mAbs Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/22/2025
6:01 PM | Wilms Joris (Reporting)
Y-mAbs Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/22/2025
6:03 PM | Gentilcore Douglas J (Reporting)
Y-mAbs Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/22/2025
6:04 PM | Gad Thomas (Reporting)
Y-mAbs Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/22/2025
6:05 PM | PFREUNDSCHUH PETER P. (Reporting)
Y-mAbs Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/16/2025
3:44 PM | LaRocca John (Reporting)
Y-mAbs Therapeutics (Issuer)
| Form 3
Initial statement of beneficial ownership of securities | |
01/13/2025
8:21 AM | Y-mAbs Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
01/10/2025
8:27 AM | Y-mAbs Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
11/14/2024
3:32 PM | Paradigm Biocapital Advisors LP (Filed by)
Y-mAbs Therapeutics (Subject)
| Form SC 13G/A | |
11/08/2024
6:18 AM | Y-mAbs Therapeutics (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
11/08/2024
5:55 AM | Y-mAbs Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
11/04/2024
1:16 PM | VANGUARD GROUP INC (Filed by)
Y-mAbs Therapeutics (Subject)
| Form SC 13G/A | |
11/04/2024
7:51 AM | Y-mAbs Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
09/17/2024
7:05 PM | Gad Thomas (Reporting)
Y-mAbs Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/17/2024
4:24 PM | Y-mAbs Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
09/13/2024
3:19 PM | Gad Thomas (Reporting)
Y-mAbs Therapeutics (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
08/12/2024
6:06 AM | Y-mAbs Therapeutics (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
08/12/2024
5:50 AM | Y-mAbs Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
07/19/2024
3:15 PM | Y-mAbs Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
07/12/2024
4:29 PM | PFREUNDSCHUH PETER P. (Reporting)
Y-mAbs Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
07/08/2024
6:59 PM | PFREUNDSCHUH PETER P. (Reporting)
Y-mAbs Therapeutics (Issuer)
| Form 3
Initial statement of beneficial ownership of securities | |
